QUEEN'S CENTRE FOR CLINICAL STUDIES (TRUST)
Supports doctors and associated healthcare professionals in their clinical training activities, regardless of age, disabilities or ethnicity.
Financial health, per its FY2025 accounts
The accounts state that total funds increased to £41,852, with unrestricted funds at £8,731 and restricted funds at £33,121 (derived from total less unrestricted). The trustees report that the Queen's Centre for Clinical Studies section has closed and its residual funds were donated to the ATLS subsidiary, which continues operations independently.
What the accounts disclose
“Reserves are held in case of course cancellations, where payment has not yet been refunded to the charity within that financial year, or here courses cannot be held, i.e during a pandemic.” — page 5
Trustees
- Dr Nichola Whitechair
- Dr Anthony Hodgetts
- Dr Matthew Heywood
- Dr Philip John Blackie
- Emma Marie Johnson
- Glenn Trevor Whitney
- Jane Ruth Daulman
- Jessica Evans
Income and spending
| Financial year end | Income | Spending |
|---|---|---|
| 31/03/2025 | £52k | £41k |
| 31/03/2024 | £32k | £36k |
| 31/03/2023 | £29k | £32k |
| 31/03/2022 | £29k | £23k |
| 31/03/2021 | £14k | £13k |
Common questions
Is QUEEN'S CENTRE FOR CLINICAL STUDIES (TRUST) financially healthy?
Per its FY2025 accounts: The accounts state that total funds increased to £41,852, with unrestricted funds at £8,731 and restricted funds at £33,121 (derived from total less unrestricted). The trustees report that the Queen's Centre for Clinical Studies section has closed and its residual funds were donated to the ATLS subsidiary, which continues operations independently. Its FY2025 accounts were independently examined.